ADA Scientific Sessions 2026 Abstract

Survodutide Induces Superior Weight Loss and Energy Expenditure Compared with Semaglutide in DIO Mice Housed at Thermoneutrality

By Mafalda Pereira, Wolfgang Rist, Bradford Hamilton, Thomas Klein

Experiments in animalsInterventions

The paper

Mafalda Pereira, Wolfgang Rist, Bradford Hamilton, Thomas Klein

Biberach

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 2565-P

doi.org/10.2337/db26-2565-p

The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
JCI Insight6 Oct 2026
Antibody reduced fat while preserving lean mass in mice
Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance